Late angiographic stent thrombosis (LAST) events with drug-eluting stents
about
Endothelial progenitor cells: what use for the cardiologist?Everolimus-eluting stents in interventional cardiologyComing safely to a stop: a review of platelet activity after cessation of antiplatelet drugsDrug-eluting stents and acute myocardial infarction: A lethal combination or friends?Perioperative management of patient with intracoronary stent presenting for noncardiac surgeryThe safety and efficacy of aspirin and clopidogrel as a combination treatment in patients with coronary heart diseaseDual antiplatelet therapy and drug eluting stents: a marriage of convenienceRapamycin regulates the expression and activity of Krüppel-like transcription factor 2 in human umbilical vein endothelial cellsThrombotic Thrombocytopenic Purpura associated with Clopidogrel: a case report and review of the literature.Incidence of side-effects of dual antiplatelet therapy with clopidogrel and aspirin after coronary stent implantation.Layer-by-layer assembly of chitosan and platelet monoclonal antibody to improve biocompatibility and release character of PLLA coated stent.Low risk of rebound events after a short course of clopidogrel in acute TIA or minor stroke.Scaffold-free in vitro arterial mimetics: the importance of smooth muscle-endothelium contactUreteroscopy in patients with coagulopathies is associated with lower stone-free rate and increased risk of clinically significant hematuria.Should antiplatelet therapy be interrupted in drug eluting stent recipients throughout the periendoscopic period? A very late stent thrombosis case report and review of the literature.Benefit of long-term dual anti-platelet therapy in patients treated with drug-eluting stents: from the NHLBI dynamic registry.A prospective, multi-centric, observational registry to evaluate performance of Excel™ DES in 'real world, all comers' patient population.Stratification of coronary artery disease patients for revascularization procedure based on estimating adverse effects.Tissue coverage of a hydrophilic polymer-coated zotarolimus-eluting stent vs. a fluoropolymer-coated everolimus-eluting stent at 13-month follow-up: an optical coherence tomography substudy from the RESOLUTE All Comers trial.Bridging therapy for early surgery in patients on dual antiplatelet therapy after drug-eluting stent implantation.Comparison of bare-metal and drug-eluting stents in patients with chronic kidney disease (from the NHLBI Dynamic Registry)Application of a temporal reasoning framework tool in analysis of medical device adverse events.Knockdown of transient receptor potential canonical-1 reduces the proliferation and migration of endothelial progenitor cells.An essential role for the Id1/PI3K/Akt/NFkB/survivin signalling pathway in promoting the proliferation of endothelial progenitor cells in vitro.In vitro and in vivo degradation of poly(D, L-lactide-co-glycolide)/amorphous calcium phosphate copolymer coated on metal stents.Can doubling the maintenance dose of clopidogrel prevent from early stent thrombosis after the primary percutaneous coronary intervention?Transplantation of EPCs overexpressing PDGFR-β promotes vascular repair in the early phase after vascular injury.Simultaneous very late stent thrombosis in multiple coronary arteries.Technology Insight: an overview of research in drug-eluting stents.Should degenerated saphenous vein grafts routinely be sealed with drug-eluting stents?Drug-eluting stents: current issues.Progressive stent technologies: new approaches for the treatment of cardiovascular diseases.New developments in coronary stent technology.Thrombelastography: current clinical applications and its potential role in interventional cardiology.Nanomedicine opportunities in cardiology.Promoting vascular regeneration as an alternative to conventional angioplasty-based intervention.Nanomedicine opportunities for cardiovascular disease with perfluorocarbon nanoparticles.External adjustment sensitivity analysis for unmeasured confounding: an application to coronary stent outcomes, Pennsylvania 2004-2008.Antiplatelet therapy in the era of drug-eluting stents: current and future perspectives.Update on stents: recent studies on the TAXUS stent system in small vessels.
P2860
Q21198698-BF291A4C-EE78-4A78-8F0C-08EF4876E2CDQ24630321-56CF2F1B-AB64-4773-935D-78296237E246Q26795403-2B0A503C-3694-42A6-B727-2A93B8778577Q26865052-72CB784D-C5A8-48E5-8699-3C87EB0EADF7Q28075834-DBD3DA09-BE01-4382-BD81-6EF17054AE39Q28200757-97E1CDDF-3FC3-4A29-A036-39695876C17AQ28222394-98FD066E-5AB3-4F90-B440-EBAE93A33EF7Q28482627-462A4938-483D-4377-A13B-C715C5DE4AEFQ33398293-E34A254F-EBE0-44D7-BCA0-86ACD587ACD0Q33410893-043CDB53-839E-40BE-9421-5EE050ECDBEFQ33870125-3F8752D5-4CC0-4182-AF7E-161C7A165170Q33899911-CD2C34D9-9215-4904-A9F0-C58ADE17BA54Q34171389-66D816B9-483A-42B9-AFB6-FAEEAF2D181AQ34255256-A1D5598C-035D-440A-A727-EDC07D8B2C1EQ34260482-57802ABE-D0C8-40FB-8F64-BEDFB9052303Q34646022-9CC01AE7-ADDD-4B6F-AF04-20422CC4F2B6Q35028661-BC902935-1A8D-42AA-9244-5DDBEEF8C539Q35108606-8A250B90-678F-4105-B4CD-F240F014BF50Q35249476-F844C0E2-267F-4521-978C-ED6BD31A630BQ35291798-7861BDFF-7D83-4988-BB17-633B32C8262BQ35549533-7B3B7DEA-8266-4F21-8453-BA7CE574C831Q35624973-A64FD909-F840-4FFA-9BF8-C455D5F5BE11Q35737474-B5F77621-068B-4F38-9C1E-50830703870FQ35788644-97DB2DDF-6249-41F2-A863-2959324C9B8AQ35793491-08F80A8E-BA93-4C27-B599-DB445CA1B704Q35945231-0F0EF3BD-0348-402F-9E92-BB689089B1D4Q36130517-FFA425FB-BCEF-4CE2-AE48-144C7F979726Q36289544-3DF159BD-6E65-436D-8986-AC13BCA8987CQ36321778-497150B7-F25B-41B9-8431-2C9464A0697FQ36335179-4BB175B3-610C-4BB4-9DC5-B2281BF3A944Q36360182-0D8920CC-92DF-4FEA-9360-22C31396033FQ36640339-39057B41-5964-42E5-994B-8E23A27FF45FQ36654375-A1403815-33D6-46EF-99E7-0E3C42EC8DEFQ36664802-2CD621BC-B5CB-4D3E-AD77-EF3C4DFD9A11Q36667383-0386D9C5-F4D9-47A7-9F4C-6FC470390F00Q36684479-59587C91-0710-4345-8452-14BFDA9D613DQ36918008-6BB5DE22-13E8-4B80-982F-4FBEB53FA345Q36925442-2F0AECF7-C1E7-48A0-9688-F61FA877ED46Q36941850-AB0FA8ED-6795-4CA8-B930-17185F260533Q36985317-AD7DA758-DE18-41A7-BC71-9636AE6A9C3B
P2860
Late angiographic stent thrombosis (LAST) events with drug-eluting stents
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Late angiographic stent thrombosis (LAST) events with drug-eluting stents
@ast
Late angiographic stent thrombosis (LAST) events with drug-eluting stents
@en
Late angiographic stent thrombosis (LAST) events with drug-eluting stents
@nl
type
label
Late angiographic stent thrombosis (LAST) events with drug-eluting stents
@ast
Late angiographic stent thrombosis (LAST) events with drug-eluting stents
@en
Late angiographic stent thrombosis (LAST) events with drug-eluting stents
@nl
prefLabel
Late angiographic stent thrombosis (LAST) events with drug-eluting stents
@ast
Late angiographic stent thrombosis (LAST) events with drug-eluting stents
@en
Late angiographic stent thrombosis (LAST) events with drug-eluting stents
@nl
P2093
P3181
P1476
Late angiographic stent thrombosis (LAST) events with drug-eluting stents
@en
P2093
Andrew T L Ong
Eugène P McFadden
Evelyn Regar
Peter P T de Jaegere
Ron T van Domburg
P304
P3181
P356
10.1016/J.JACC.2005.02.086
P407
P577
2005-06-21T00:00:00Z